Joseph Lusardi

Joseph Lusardi

President & CEO

Mr. Lusardi is a pioneer in the U.S. cannabis industry and is credited with opening one of the first medical cannabis operations on the East Coast. Mr. Lusardi has almost a decade of cannabis experience through which he has cultivated bottom-up expertise in cannabis company implementation and management, as well as 20 years’ experience in finance, private equity and entrepreneurship. He previously held executive positions at financial services companies including Liberty Mutual Group, Fidelity Investments, and Affiliated Managers Group. At Curaleaf, Mr. Lusardi has been instrumental in developing an organizational strategy focused on bringing the Company’s commitment to the advancement of cannabis science to all Curaleaf subsidiaries, and, ultimately, patients in need of medical cannabis. To support this effort, he raised over $500 million dollars to invest into the Company’s infrastructure, research and development, and staff. Mr. Lusardi continues to guide corporate strategy with a focused view on the continual improvement of best practices. Mr. Lusardi has a B.B.A. from The Catholic University of America and a M.B.A. from Boston College

Stuart Wilcox

Stuart Wilcox

Chief Operating Officer

Stuart Wilcox is a seasoned operational leader with more than 25 years of experience in global supply chain, operations start-up, acquisitions, and new product commercialization for market leaders. He joined Curaleaf from Hostess Brands where he was the SVP/COO of Operations. Prior to Hostess, he held global senior operational leadership positions at The Original Cakerie, a private Canadian company, Fresh Express/Chiquita and ConAgra.

Jonathan Faucher

Jonathan Faucher

EVP, Finance

Jon Faucher is an accomplished finance professional with experience working in fast-paced small to mid-sized high-tech organizations. He brings extensive experience developing and implementing financial systems to drive business decisions. Prior to joining Curaleaf, Mr. Faucher held finance positions at BionX Medical Technologies and Reveal Imaging Technologies.

Carolyn Fedigan

Carolyn Fedigan

SVP, Human Resources

Carolyn Fedigan has over 25 years of experience in corporate human resources, working in a wide variety of industries including financial services, high-tech, biotechnology and public relations. Prior to Curaleaf, Ms. Fedigan served as Director of Human Resources at Audax Group and held human resource leadership roles at Harvard University, SHIFT Communications and Advent International Corporation.

Katrina Yolen

Katrina Yolen

SVP, Marketing

Katrina Yolen is a seasoned marketing executive with over 20 years of experience working in mid-sized and large consumer packaged goods companies, as well as in startups. Prior to Curaleaf, Ms. Yolen served as Vice President of Marketing at Dancing Deer Baking Co., Director of Marketing at Weetabix North America, and held senior marketing roles at GlaxoSmithKline and Kraft Foods.

Ed Kelenchuk

Ed Kelenchuk

SVP, Business Development

Ed Kelenchuk served as Investment Director for The Sputnik Group from 2015 to 2018, leading its portfolio management, including financing and mergers and acquisitions for Curaleaf. Mr. Kelenchuk has over 15 years of Corporate Finance Experience, ranging from investment banking at Merrill Lynch and Renaissance Capital to principal investments at TPG Capital and Och-Ziff, among others, focusing on emerging industries.

Christine Rigby

Christine Rigby

SVP, Investor Relations

Christine Rigby has over 20 years of experience in capital markets, investment strategy, institutional sales and private equity. Prior to joining Curaleaf, Ms. Rigby spent eight years as Vice President and Head Trader at The Sputnik Group and 14 years as Senior Vice President, Middle Markets Institutional Sales at Citigroup Global Market, Inc. and was responsible for overseeing $2 billion in client assets.

Robert Winnicki

Robert Winnicki

SVP, Research and Product Development

Robert Winnicki is a leading cannabis chemist with expertise in extraction, formulation and cannabis product manufacturing. As a member of Curaleaf's Medical Advisory Board, Mr. Winnicki leads Curaleaf's product development team. Prior to joining Curaleaf, Mr. Winnicki was a certified laboratory director in Colorado and former head of R&D in medical cannabis cloning and cannabinoid synthesis.

Ed Conklin

Ed Conklin

SVP, Government Relations

Ed Conklin brings over 30 years of experience in government and public relations management and strategy, including leading lobbying and grassroots engagement efforts. Mr. Conklin served as Senior Director and Chief of Staff of Global Government and Public Affairs at McDonald's and was Director of Public Relations for Jones Intercable Midwest Division and Director of Operations for Centel Cable Television.

Chris Melillo

Chris Melillo

SVP, Retail Operations

Mr. Melillo formerly served as Senior Director of Stores North America for Nike, Inc. (NYSE: NKE), and Vice President of Stores for DTLR/Villa, a leading footwear and apparel retailer. Mr. Melillo has more than 20 years of experience in retail leadership and store operations. He has been instrumental in retail expansions, store design/construction, merchandising and omnichannel commerce in hundreds of stores, in addition to developing and leading retail teams across the country.

Gretchen McCarthy

Gretchen McCarthy

VP, Dispensary Operations

Gretchen McCarthy has managed medical cannabis dispensaries for the past seven years, helping to scale operations and rapidly expand the business across multiple states. Prior to Curaleaf, Ms. McCarthy spent four years as Dispensary Operations Manager at Maine Organic Therapy, and was responsible for maintaining the dispensary's high standards for patient care, as well as human resources, marketing and logistics.

Peter Clateman

Peter Clateman

General Counsel

Peter Clateman has more than 20 years of legal experience in investing and investment funds, including more than 15 years as general counsel. He has served as GC and CCO of The Sputnik Group and Renaissance Capital, as well as VR Capital, an award-winning, distressed-asset fund with more than $2 billion under management. Mr. Clateman also served as head of Legal and was a Management Board Member of UC Rusal during its acquisition of SUAL and assets of Glencore to become the world's biggest aluminum company. He previously was an associate with Skadden Arps Slate Meagher and Flom.

John Dol

John Dol

VP, Cultivation

John Dol has over 20 years of experience in the agricultural industry. Before joining Curaleaf, Mr. Dol served as Director of Operations for Maine's largest commercial scale tomato producer, Backyard Farms, and led the startup and management of 144 acres of modern day cutting-edge greenhouses and cultivation facilities.

Jessie Kater

Jessie Kater

VP, Product Research

Jessie Kater has over 15 years of experience in product development and commercialization across defense, pharmaceutical and cannabis markets. Prior to Curaleaf, Mr. Kater worked at Waters Corporation where he led sales and business development in the Cannabis market across the Western US and Canada. Additionally, he was the co-founder of c3 Labs, the first cannabis contract research organization on the West Coast.

Keisha Brice

Keisha Brice

VP, Compliance

Keisha Brice previously served as Director of Compliance and Operational Regulatory Risk Management at The Dimock Center. Prior to that, Keisha was the Assistant Program Manager at Bay Cove Human Services.

Matthew Harrell

Matthew Harrell

VP, Government Relations

Matthew Harrell previously served as the Government Relations Manager for McDonald's. Prior to that, Matthew was the Governmental Relations Specialist for the North Carolina School Boards Association.